logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 1
  • 1
    Frymann, Robert James
    Born in September 1969
    Individual (8 offsprings)
    Officer
    2018-12-17 ~ now
    OF - Director → CIF 0
    Mr Robert James Frymann
    Born in September 1969
    Individual (8 offsprings)
    Person with significant control
    2018-12-17 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
parent relation
Company in focus

SUSSEX UROLOGY LTD

Period: 2018-12-17 ~ now
Company number: 11730711
Registered name
SUSSEX UROLOGY LTD - now
Standard Industrial Classification
86220 - Specialists Medical Practice Activities
Brief company account
Debtors
Current
75,192 GBP2025-03-31
95,672 GBP2024-03-31
Cash at bank and in hand
27,049 GBP2025-03-31
10,898 GBP2024-03-31
Current Assets
523,982 GBP2025-03-31
435,990 GBP2024-03-31
Creditors
Current, Amounts falling due within one year
-28,617 GBP2025-03-31
Total Assets Less Current Liabilities
495,365 GBP2025-03-31
406,628 GBP2024-03-31
Net Assets/Liabilities
486,938 GBP2025-03-31
406,628 GBP2024-03-31
Equity
Called up share capital
140 GBP2025-03-31
130 GBP2024-03-31
130 GBP2023-03-31
Retained earnings (accumulated losses)
461,517 GBP2025-03-31
371,132 GBP2024-03-31
284,482 GBP2023-03-31
Equity
486,938 GBP2025-03-31
406,628 GBP2024-03-31
285,751 GBP2023-03-31
Profit/Loss
Retained earnings (accumulated losses)
90,600 GBP2024-04-01 ~ 2025-03-31
126,877 GBP2023-04-01 ~ 2024-03-31
Profit/Loss
90,600 GBP2024-04-01 ~ 2025-03-31
126,877 GBP2023-04-01 ~ 2024-03-31
Comprehensive Income/Expense
Retained earnings (accumulated losses)
100,685 GBP2024-04-01 ~ 2025-03-31
92,650 GBP2023-04-01 ~ 2024-03-31
Comprehensive Income/Expense
90,600 GBP2024-04-01 ~ 2025-03-31
126,877 GBP2023-04-01 ~ 2024-03-31
Dividends Paid
Retained earnings (accumulated losses)
-10,300 GBP2024-04-01 ~ 2025-03-31
-6,000 GBP2023-04-01 ~ 2024-03-31
Dividends Paid
-10,300 GBP2024-04-01 ~ 2025-03-31
-6,000 GBP2023-04-01 ~ 2024-03-31
Issue of Equity Instruments
Called up share capital
10 GBP2024-04-01 ~ 2025-03-31
Issue of Equity Instruments
10 GBP2024-04-01 ~ 2025-03-31
Average Number of Employees
12024-04-01 ~ 2025-03-31
12023-04-01 ~ 2024-03-31
Trade Debtors/Trade Receivables
Current, Amounts falling due within one year
49,195 GBP2025-03-31
Amounts falling due within one year, Current
50,820 GBP2024-03-31
Other Debtors
Current, Amounts falling due within one year
25,997 GBP2025-03-31
Amounts falling due within one year, Current
44,852 GBP2024-03-31
Debtors
Current, Amounts falling due within one year
75,192 GBP2025-03-31
Amounts falling due within one year, Current
95,672 GBP2024-03-31
Par Value of Share
Class 1 ordinary share
12024-04-01 ~ 2025-03-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
100 shares2025-03-31
100 shares2024-03-31
Par Value of Share
Class 2 ordinary share
12024-04-01 ~ 2025-03-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
10 shares2025-03-31
10 shares2024-03-31
Par Value of Share
Class 3 ordinary share
12024-04-01 ~ 2025-03-31
Number of Shares Issued (Fully Paid)
Class 3 ordinary share
10 shares2025-03-31
10 shares2024-03-31
Par Value of Share
Class 4 ordinary share
12024-04-01 ~ 2025-03-31
Number of Shares Issued (Fully Paid)
Class 4 ordinary share
10 shares2025-03-31
10 shares2024-03-31
Number of Shares Issued (Fully Paid)
140 shares2025-03-31
130 shares2024-03-31
Nominal value of allotted share capital
140 GBP2024-04-01 ~ 2025-03-31
130 GBP2023-04-01 ~ 2024-03-31

  • SUSSEX UROLOGY LTD
    Info
    Registered number 11730711
    Wallesley House 204 London Road, Waterlooville, Hampshire PO7 7AN
    PRIVATE LIMITED COMPANY incorporated on 2018-12-17 (7 years 7 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2026-01-09
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.